• In Vivo CRISPR Therapy is One Step Closer to the Clinic

    Bio-IT World | A one-time, in vivo CRISPR gene-editing therapy from Intellia Therapeutics could become the first approved treatment of its kind for patients with hereditary angioedema. The experimental therapy, lonvoguran ziclumeran (lonvo-z), reduced hereditary angioedema (HAE) attacks by 87% in a phase 3 trial and could be submitted for regulatory review in the United States and Europe within the next year.

    Jul 23, 2026

  • Different Teams, Same Problem

    Bio-IT World | Receiving a Bio-IT World Best of Show Award for OmicsHQ was a tremendous honor. More importantly, it provided an opportunity to engage with the researchers, data scientists, and technology leaders who ultimately determine whether products like ours succeed or fail.

    Jul 22, 2026

  • Winning Best of Show Again: A Reflection on MLADU, Research Data, and the Bio-IT World Community

    Bio-IT World | When Dantech Corporation created MLADU, we were not trying to build a product that would win awards. We were trying to solve a problem that we kept seeing in the real world: research organizations, consortia, biopharma teams, clinical partners, and technology teams needed to move important data securely, reliably, and with accountability, but the process was often far more slow and difficult than it should be.

    Jul 21, 2026

  • With AWS Help, UK Group Moves Toward Global AMR Intelligence Platform

    Bio-IT World | Amazon Web Services has come alongside the UK’s The Fleming Initiative, offering up to several million pounds worth of cloud and AI technology, as well as technical support, for the Initiative’s global antimicrobial resistance (AMR) intelligence platform.

    Jul 16, 2026

  • CFDE Promotes Collaboration to Build Creative and Practical Solutions to Data Challenges during the Bio-IT Hackathon

    Bio-IT World | The 2026 Bio-IT FAIR Data Hackathon kicked-off the 25th Bio-IT World Conference & Expo by welcoming 32 data scientists, software developers, students, and life science professionals to address real-world data challenges using Open Source and FAIR (Findable, Accessible, Interoperable, Reusable) data principles.

    Jul 15, 2026

  • CFDE Promotes Collaboration to Build Creative and Practical Solutions to Data Challenges during the Bio-IT Hackathon

    Bio-IT World | The 2026 Bio-IT FAIR Data Hackathon kicked-off the 25th Bio-IT World Conference & Expo by welcoming 32 data scientists, software developers, students, and life science professionals to address real-world data challenges using Open Source and FAIR (Findable, Accessible, Interoperable, Reusable) data principles.

    Jul 15, 2026

  • How Sugar on Brain Cells May Be Driving Alzheimer’s and How a Common Joint Supplement May Be Making It Worse

    Bio-IT World |  While most of the research on Alzheimer’s Disease (AD) in the last few decades has focused on amyloid-beta plaques and the tau tangles—the misfolded debris cluttering and hindering normal brain function—a group at the University of Florida has identified a new angle of pursuit by performing an unbiased survey of all the different fats, sugars, and small molecule metabolites in the brains of Alzheimer’s patients.

    Jul 14, 2026

  • Signal Management Isn’t Broken; It Simply Belongs to a Previous Era

    Bio-IT World | Drug safety discussions rarely take into account how pharmacovigilance might change if the adverse event case-processing bottleneck was eliminated altogether. Yet this reality is within reach now thanks to advanced technology. As an industry we have digitized the paperwork and accelerated individual steps, but the overall workflow remains largely sequential, manual at its core, and oriented around periodic snapshots rather than continuous monitoring.

    Jul 10, 2026

  • Network Effects: John Quackenbush on How Networks Illuminate Biology Beyond Gene Expression

    Bio-IT World | A group of researchers is sounding the alarm: the publicly funded data infrastructure underpinning virtually all of modern biomedical research is fragile, underfunded, and increasingly at risk. It is up to us to safeguard it. At a session at last month’s Bio-IT World Conference & Expo, Douaa Mugahid, PhD, Data Officer at the Hi-IMPAcTB Consortium at the Harvard School of Public Health moderated a panel of academics, investors, and consultants to take on the future of public data and software infrastructure.

    Jul 9, 2026